Rua Bioscience’s first CBD product now prescribable
Produced at purpose-built Gisborne facility and distributed by CDC Pharmaceuticals.
NBR Staff
Tue, 19 Apr 2022
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
NZX-listed medical cannabis firm Rua Bioscience has launched its first medicine, Rua CBD100, so registered medical practitioners are now able to prescribe it in patient treatment plans.
Rua is one of just two companies in New Zealand manufacturing medicinal cannabis that has met the minimum
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Subscribe Now
Monthly Premium Online Subscription
NZ$49.95 / monthly
Subscribe Now
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Subscribe Now
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Subscribe Now
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
NBR Staff
Tue, 19 Apr 2022
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
